Products
2681 products
Code | Description | Unit |
---|---|---|
EPY0001536 | Fludarabine for system suitability | EP unit |
EPY0000419 | Fludarabine phosphate | EP unit |
EPF0180000 | Fludrocortisone acetate | EP unit |
EPF0188000 | Flumazenil - Reference Spectrum | EP unit |
EPY0000335 | Flumazenil impurity B - ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo [1,5-a][1,4]benzodiazepine-3-carboxylate | EP unit |
EPF0189000 | Flumequine | EP unit |
EPF0189020 | Flumequine impurity B - ethyl(RS)-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j] quinolizine-2-carboxylate | EP unit |
EPF0188500 | Flumetasone pivalate | EP unit |
EPF0189900 | Flunarizine dihydrochloride | EP unit |
EPY0000265 | Flunarizine dihydrochloride - Reference Spectrum | EP unit |
EPY0000266 | Flunarizine dihydrochloride for system suitability | EP unit |
EPY0000169 | Flunitrazepam - Reference Spectrum | EP unit |
EPY0000444 | Flunixin impurity B - 2-methyl-3-(trifluoromethyl)aniline | EP unit |
EPY0000445 | Flunixin impurity C - ethyl 2-chloropyridine-3-carboxylate | EP unit |
EPY0000443 | Flunixin meglumine | EP unit |
EPF0200000 | Fluocinolone acetonide | EP unit |
EPY0001711 | Fluocinolone acetonide for peak identification | EP unit |
EPY0001710 | Fluocinolone acetonide for system suitability | EP unit |
EPF0230000 | Fluocortolone pivalate | EP unit |
EPY0000796 | Fluorescein | EP unit |
EPY0000804 | Fluorescein impurity C - 2-(2,4-dihydroxybenzoyl)benzoic acid | EP unit |
EPF0245000 | Fluoresceine sodium - Reference Spectrum | EP unit |
EPF0250000 | Fluorouracil | EP unit |
EPY0000762 | Fluorouracil impurity A - pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid) | EP unit |
EPY0000763 | Fluorouracil impurity B - dihydropyrimidine-2,4,5(3H)-trione (isobarbituric acid or 5-hydroxyuracil) | EP unit |
EPY0000764 | Fluorouracil impurity C - pyrimidine-2,4(1H,3H)-dione (uracil) | EP unit |
EPY0000765 | Fluorouracil impurity F - 2-ethoxy-5-fluoropyrimidin-4(1H)-one (2-ethoxy-5-fluorouracil) | EP unit |
EPY0000791 | Fluorouracil impurity mixture | EP unit |
EPF0253000 | Fluoxetine hydrochloride | EP unit |
EPF0253030 | Fluoxetine impurity C - (RS)-methyl-[3-phenyl-3-(3-trifluoromethylphenoxy) -propyl]amine | EP unit |
EPY0000064 | Flupentixol dihydrochloride | EP unit |
EPY0000067 | Flupentixol impurity D - 2-[2-[4-[3-[(EZ)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl] piperazin-1-yl]ethoxy]ethanol | EP unit |
EPY0000078 | Flupentixol impurity F - 2-[4-[(EZ)-3-[(9RS)-2-(trifluoromethyl)-9H-thioxanthen-9-yl)prop-2-enyl]piperazin-1-yl]ethanol | EP unit |
EPF0260000 | Fluphenazine decanoate | EP unit |
EPF0280000 | Fluphenazine dihydrochloride | EP unit |
EPY0000009 | Fluphenazine enantate | EP unit |
EPY0000708 | Fluphenazine impurity mixture | EP unit |
EPY0000298 | Fluphenazine octanoate | EP unit |
EPY0000299 | Fluphenazine sulphoxide | EP unit |
EPY0000211 | Flurazepam monohydrochloride - Reference Spectrum | EP unit |
EPF0285200 | Flurbiprofen | EP unit |
EPF0285202 | Flurbiprofen impurity A - (2RS)-2-(biphenyl-4-yl)propanoic acid | EP unit |
EPY0000236 | Fluspirilene | EP unit |
EPY0000375 | Fluspirilene impurity C - 8-[4,4-bis((4-fluorophenyl)butyl]-3-(hydroxymethyl)-1- phenyl-1,3,8-triazaspiro[4.5]decan-4-one | EP unit |
EPF0285600 | Flutamide | EP unit |
EPY0001591 | Flutamide for system suitability | EP unit |
EPY0000221 | Fluticasone impurity D - S-methyl 6a,9a-difluoro-11b-hydroxy-16a-methyl-3-oxo-17a-propionyloxy-androsta-1,4-diene-17 beta-carbothioate (S-methyl derivative) | EP unit |
EPY0000284 | Fluticasone propionate | EP unit |
EPY0001754 | Fluticasone propionate for impurity C identification | EP unit |
EPY0001755 | Fluticasone propionate for impurity G identification | EP unit |
EPF0290000 | Flutrimazole | EP unit |
EPF0290010 | Flutrimazole impurity B - (RS)-(2-fluorophenyl)(4-fluorophenyl)phenylmethanol | EP unit |
EPY0001082 | Fluvastatin for system suitability | EP unit |
EPY0001090 | Fluvastatin sodium | EP unit |
EPY0000853 | Fluvoxamine for system suitability | EP unit |
EPY0000916 | Fluvoxamine impurity D - 5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one | EP unit |
EPY0000854 | Fluvoxamine maleate | EP unit |
EPY0000386 | Foeniculin for peak identification Anise oil | EP unit |
EPF0300000 | Folic acid | EP unit |
EPY0001242 | Folic acid impurity A - (2S)-2-[(4-aminobenzoyl)amino]pentanedioic acid (N-(4-aminobenzoyl)-l-glutamic acid) | EP unit |
EPY0001243 | Folic acid impurity D - 4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid (pteroic acid) | EP unit |
EPY0001629 | Follitropin | 0.2 mL |
EPY0001627 | Follitropin for peptide mapping and glycan analysis | EP unit |
EPY0000339 | Formoterol for impurity I identification | EP unit |
EPF0372000 | Formoterol fumarate dihydrate | EP unit |
EPY0000340 | Formoterol fumarate for system suitability | EP unit |
EPF0380000 | Formylfolic acid - 10-Formylfolic acid | EP unit |
EPF0389004 | Foscarnet impurity B - disodium(ethoxyoxydophosphanyl)formate | EP unit |
EPY0001222 | Foscarnet impurity D - Ethyl (diethoxyphosphinyl)formate | EP unit |
EPY0001213 | Foscarnet impurity mixture | EP unit |
EPF0389000 | Foscarnet sodium hexahydrate | EP unit |
EPY0000782 | Fosfomycin calcium | EP unit |
EPF0399950 | Fosfomycin sodium - Reference Spectrum | EP unit |
EPF0400000 | Fosfomycin trometamol | EP unit |
EPY0001228 | Fosinopril impurity A - (2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl] acetyl]pyrrolidine-2-carboxylic acid | EP unit |
EPY0001229 | Fosinopril impurity B - (2RS,4RS)-4-cyclohexyl-1-[[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid | EP unit |
EPY0001230 | Fosinopril impurity C - mixture of (2S,4S)-4-cyclohexyl-1-[[(S)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid and (2S,4S)-4-cyclohexyl-1-[[(R)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid | EP unit |
EPY0001231 | Fosinopril impurity D - (2S,4R)-4-cyclohexyl-1-[[(R)-[(1S)-2-methyl- 1-(1-oxopropoxy)propoxy](4-phenylbutyl) phosphoryl]acetyl]pyrrolidine-2-carboxylic acid | EP unit |
EPY0001232 | Fosinopril impurity I - [(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl) phosphoryl]acetic acid | EP unit |
EPY0001233 | Fosinopril impurity K - (2S,4S)-4-cyclohexyl-1-(2,2-dimethyl-1-oxopropyl) pyrrolidine-2-carboxylic acid | EP unit |
EPY0001212 | Fosinopril impurity mixture | EP unit |
EPY0001227 | Fosinopril sodium | EP unit |
EPF0450000 | Framycetin sulphate | EP unit |
EPF0550000 | Fructose (Laevulose) | EP unit |
EPY0001399 | Fulvestrant | EP unit |
EPY0001413 | Fulvestrant for system sitability | EP unit |
EPF0600000 | Fumaric acid | EP unit |
EPF0700000 | Furosemide | EP unit |
EPY0001493 | Furosemide for peak identification | EP unit |
EPF0702000 | Furosemide impurity A - 2-chloro-4-(furfurylamino)-5-sulphamoylbenzoic acid | EP unit |
EPY0001411 | Fusidic acid | EP unit |
EPY0001394 | Fusidic acid for peak identification | EP unit |
EPY0001384 | Fusidic acid impurity mixture | EP unit |
EPY0001280 | Gabapentin | EP unit |
EPY0001281 | Gabapentin impurity A - 2-azaspiro[4.5]decan-3-one | EP unit |
EPY0001348 | Gabapentin impurity B - (1-cyanocyclohexyl)acetic acid | EP unit |
EPY0001349 | Gabapentin impurity D - [1-[(3-oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexyl]acetic acid | EP unit |
EPY0001804 | Gadobutrol for peak identification | 20 mg |
EPY0001803 | Gadobutrol monohydrate | 210 mg |
EPY0001875 | Gadodiamide | EP-unit |